3rd Annual

AML-ALL

Focus Meeting 2024

calendar icon

Estancia La Jolla Hotel, La Jolla, CA

calendar icon

August 11 - 13, 2024

Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the AML-ALL Focus Meeting 2024, to be held at on August 11 - 13, 2024.

Centered around the theme “Updating Knowledge & Clinical Practice in 2024” this meeting provides pivotal collaboration aimed at advancing AML-ALL research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of AML-ALL Focus Meeting 2024:

Headshot of Chair: Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

Headshot of Chair: Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

Headshot of Chair: Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY

Thanks to Our Supporters

Agenda & Faculty

August 11, 2024 | Day 1

01:00 PM
Registration Opens
01:50 PM
Opening Remarks – Ryan Fitzpatrick, CEO, MD Education

Session I


Moderated by:

Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
02:00 PM
CLL Highlights
Headshot of Nitin Jain, MD

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX
02:20 PM
MDS Highlights
Headshot of Rami Komrokji, MD

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL
02:40 PM
Panel Discussion
03:00 PM
Coffee Break & Networking

Session II


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
03:20 PM
BPDCN Highlights
Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX
03:40 PM
Pediatric Leukemia Highlights
Headshot of Branko Cuglievan, MD

Branko Cuglievan, MD

MD Anderson Cancer Center, Houston, TX
04:00 PM
CML Highlights
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
04:20 PM
Panel Discussion
04:40 PM
Adjourn

August 12, 2024 | Day 2

07:45 AM
Registration Opens

Session III


Moderated by:

Headshot of Charlie Craddock, MD

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK
Headshot of Courtney DiNardo, MD

Courtney DiNardo, MD

MD Anderson Cancer Center, Houston, TX
08:30 AM
Current and Future Research Directions in AML
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
08:50 AM
The Genetic Landscape and Molecular Diagnostics in AML
Headshot of Joseph D. Khoury, MD

Joseph D. Khoury, MD

University of Nebraska, Lincoln, NE
09:10 AM
Optimizing Frontline Therapy for FLT3 Mutated AML Patients Eligible for Intensive
Headshot of Harry P. Erba, MD

Harry P. Erba, MD

Duke University, Durham, NC
09:30 AM
Genomic Strategies to Guide the Choice of Invasive Treatment Strategies in Non-FLT3m AML
Headshot of Ghayas Issa, MD

Ghayas Issa, MD

MD Anderson Cancer Center, Houston, TX
09:50 AM
Diagnostic and Molecular Work-up of Newly Diagnosed AML – The Pathologist’s Perspective
Headshot of Sanam Loghavi, MD

Sanam Loghavi, MD

MD Anderson Cancer Center, Houston, TX
10:10 AM
Panel Discussion
10:30 AM
Coffee Break & Networking

Session IV


Moderated by:

Headshot of Ibrahim Aldoss, MD

Ibrahim Aldoss, MD

City of Hope Comprehensive Cancer Center, Duarte, CA
Headshot of Anjali Advani, MD

Anjali Advani, MD

Mayo Clinic, Cleveland, OH
10:50 AM
Molecular Biology
Headshot of Charles Mullighan, MD

Charles Mullighan, MD

St. Jude Children’s Research Hospital, Memphis, TN
11:10 AM
Philadelphia +ve ALL
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
11:30 AM
Ph-ve ALL MRD
Headshot of Aaron Logan, MD

Aaron Logan, MD

UCSF Helen Diller Family Comprehensive Cancer Center, CA
11:50 AM
New Targets in ALL
Headshot of Cristina Papayannidis, MD

Cristina Papayannidis, MD

University of Bologna, Italy
12:10 PM
Panel Discussion
12:30 PM
Lunch Break & Faculty and Fellows Photo
01:20 PM
Independent Expert Discussion supported by Daiichi Sankyo

Session V


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
02:05 PM
Updates on the Management and Mechanisms of Resistance in R/R FLT3m AML
Headshot of Alexander Perl, MD

Alexander Perl, MD

Perelman School of Medicine, Philadelphia, PA
02:25 PM
Emerging Strategies to Improve Outcome of Allo-transplant in AML
Headshot of Charlie Craddock, MD

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK
02:45 PM
How do I Assess for MRD in Clinical Practice and How do I Use MRD to Guide Post-remission Therapy
Headshot of Farhad Ravandi, MD

Farhad Ravandi, MD

MD Anderson Cancer Center, Houston, TX
03:05 PM
How do I use IDH Inhibitors in Frontline and R/R Setting: Single Agent Versus Combinations
Headshot of Courtney DiNardo, MD

Courtney DiNardo, MD

MD Anderson Cancer Center, Houston, TX
03:25 PM
Current Status and Future Directions with Menin Inhibitors in AML
Headshot of Eytan Stein, MD

Eytan Stein, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
03:45 PM
Panel Discussion
04:05 PM
Coffee Break & Networking

Session VI


Moderated by:

Headshot of Bijal Shah, MD

Bijal Shah, MD

Moffitt Cancer Center, Tampa, FL
Headshot of Nitin Jain, MD

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX
04:25 PM
Integration of Immune-therapy into Frontline ALL – HCVAD Experience
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
04:45 PM
Integration of Immune-therapy into Frontline ALL – Regimens
Headshot of Mark Litzow, MD

Mark Litzow, MD

MD Anderson Cancer Center, Houston, TX
05:05 PM
AYA ALL
Headshot of Wendy Stock, MD

Wendy Stock, MD

The University of Chicago Medicine, Chicago, IL
05:25 PM
Transplant in ALL
Headshot of Ibrahim Aldoss, MD

Ibrahim Aldoss, MD

City of Hope Comprehensive Cancer Center, Duarte, CA
05:45 PM
Panel Discussion
06:05 PM
Adjourn

August 13, 2024 | Day 3

08:00 AM
Registration Opens

Session VII


Moderated by:

Headshot of Eytan Stein, MD

Eytan Stein, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
Headshot of Tapan Kadia, MD

Tapan Kadia, MD

MD Anderson Cancer Center, Houston, TX

Debate: Upfront triplets vs sequential therapies for the treatment of AML

09:00 AM
The Case for Sequential Therapies
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
09:10 AM
The Case for Upfront Triplets
Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
09:20 AM
Debate Discussion
09:30 AM
Developing Immune and Cellular Therapies in AML
Headshot of Yasmin Abaza, MD

Yasmin Abaza, MD

Northwestern University Feinberg School of Medicine, Chicago, IL
09:50 AM
Panel Discussion
10:10 AM
Coffee Break & Networking

Session VIII


Moderated by:

Headshot of Eytan Stein, MD

Eytan Stein, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
Headshot of Tapan Kadia, MD

Tapan Kadia, MD

MD Anderson Cancer Center, Houston, TX
10:30 AM
Older ALL
Headshot of Anjali Advani, MD

Anjali Advani, MD

Mayo Clinic, Cleveland, OH
10:50 AM
BC2 Inhibitors in AML
Headshot of Daniel J. DeAngelo, MD

Daniel J. DeAngelo, MD

Dana-Farber Cancer Institute, Boston, MA
11:10 AM
PH – Lite ALL
Headshot of Marina Konopleva, MD

Marina Konopleva, MD

Albert Einstein College of Medicine, New York City, NY
11:30 AM
New Drugs in T-Cell
Headshot of Nitin Jain, MD

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX
11:50 AM
Panel Discussion
12:10 PM
Lunch Break & Networking

Session IX


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
Headshot of Ghayas Issa, MD

Ghayas Issa, MD

MD Anderson Cancer Center, Houston, TX
01:00 PM
Mechanisms of Resistance and Novel Combinations with Venetoclax Based Therapies in AML
Headshot of Marina Konopleva, MD

Marina Konopleva, MD

Albert Einstein College of Medicine, New York City, NY
01:20 PM
Optimizing Maintenance Therapy in AML Post-consolidation and Post-transplant
Headshot of Tapan Kadia, MD

Tapan Kadia, MD

MD Anderson Cancer Center, Houston, TX
01:40 PM
Treatment of AML Transformed from MDS or MPN
Headshot of Hetty Carraway, MD

Hetty Carraway, MD

Cleveland Clinic, Cleveland, OH
02:00 PM
Optimizing SCT Approaches Including Conditioning and Maintenance in AML
Headshot of Uday R. Popat, MD

Uday R. Popat, MD

MD Anderson Cancer Center, Houston, TX
02:20 PM
Panel Discussion
02:40 PM
Coffee Break & Networking

Session X


Moderated by:

Headshot of Wendy Stock, MD

Wendy Stock, MD

The University of Chicago Medicine, Chicago, IL
Headshot of Marina Konopleva, MD

Marina Konopleva, MD

Albert Einstein College of Medicine, New York City, NY
03:00 PM
CAR-T: Finite Therapy
Headshot of Jae Park, MD

Jae Park, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
03:20 PM
CAR-T: Bridging for ASCT
Headshot of Bijal Shah, MD

Bijal Shah, MD

Moffitt Cancer Center, Tampa, FL
03:40 PM
Future of ALL
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
04:00 PM
Panel Discussion
04:20 PM
Adjourn

Rebecca Hill

Project Manager

How long has Rebecca Hill been in the business?

Rebecca Hill has been with MD Education since 2022

About Rebecca Hill

I am a dedicated Senior Project Manager at MD Education, specialising in coordinating global medical conferences. I have a passion for organisation and detail, and I pride myself on ensuring seamless execution of educational events. My expertise lies in orchestrating logistics and fostering collaboration among diverse teams.